A real-world cohort of patients with metastatic pancreatic adenocarcinoma (mPDAC) demonstrated that prophylaxis therapy to alleviate toxic effects was ...
Baseline geriatric vulnerabilities and QOL scores are associated with survival after chemotherapy in older adults with metastatic pancreatic cancer, researchers found.
Generally, kidney cancer cells don’t respond well to chemo, which is why it’s not often a standard treatment. It’s usually an option after targeted treatments and immunotherapy drugs have already been ...